Joaquim Segalés

Autor

Joaquim Segalés i Coma was born in Vic (Barcelona) in 1968, he graduated at the Veterinary Faculty of the Universitat Autónoma de Barcelona (UAB) in 1991. He then received a doctorate in Veterinary Science in 1996 at the same university after having spent 15 months at the University of Minnesota (UM) in the USA, under the codirectorship of Dr. Mariano Domingo (UAB) and Dr. Carlos Pijoan (UM). In 2000 he achieved a diploma at the European College of Veterinary Pathology (ECVP). In year 2004 he graduated at the European College of Porcine Health and Management (ECPHM), of which he is a founding member and its current vice-president. He currently works as professor at the Department of Animal Anatomy and Welfare at the Veterinary Faculty of the UAB, where he teaches in the area of pathologic anatomy and porcine clinic. He is also the Director of the Centre de Recerca en Sanitat Animal (CReSA).

Dr. Segalés has taken part in numerous research projects, at both a national and a European level. He is especially skilled in different porcine diseases and has collaboration agreements with different enterprises, both national and European, that are involved in the sector. Of the many lines of research that he has participated in, the most important are the Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), Haemophilus parasuis, the Aujeszky Disease Virus (ADV), the Hepatitis E Virus (HEV), torque teno sus virus and diseases associated with Porcine Circovirus type 2 (PCV2). It is also worth mentioning that Dr. Segalés participated in the first identification in Spain of the Post-weaning Multi-System Wasting Syndrome or Porcine Circovirus in 1997 and of the Porcine Dermatitis and Nephropathy Syndrome in 1996. As a result of these investigations he is the co-author of more than 200 articles published in international scientific journals, as well as being co-author of ten chapters of books with international prestige of which perhaps the most important is Porcine circovirus diseases in the 9th and 10th edition of the book Diseases of Swine. He is also the co-author of a book on swine livestock necropsy as well as three books on clinical cases in swine.

Updated CV 14-May-2013

See more
CReSA - UAB
Spain
TwitterLinkedinTelegramTelegram
3 Likecomment
share
My favorites
TwitterLinkedinTelegramTelegram
4 Likecomment
share
My favorites
TwitterLinkedinTelegramTelegram
6 Likecomment
share
My favorites
TwitterLinkedinTelegramTelegram
4 Likecomment
share
My favorites
TwitterLinkedinTelegramTelegram
6 Likecomment
share
My favorites
TwitterLinkedinTelegramTelegram
8 Likecomment
share
My favorites
TwitterLinkedinTelegramTelegram
10 Likecomment
share
My favorites
TwitterLinkedinTelegramTelegram
9 Like3 Comments
share
My favorites
07-Mar-2018Marius Opreain my opinion, sow blanket vaccination against PCV2 will have a big impact in pigs vaccination against PCV2. Some farmers are happy that are vaccinating all the sows at once, but they forget about piglets that are born from those sows. Depending on status of sows at vaccination time (lactation or various age of gestation) piglets will have different levels of MDA and it is mandatory to make ELISA checking before vaccination
TwitterLinkedinTelegramTelegram
Three months pigs with PCV2-SD. Note the marked spine, indicative of growth retardation, and body pallor

The challenge of Porcine Circovirus type 2 (PCV2) intra-specific taxonomic classification

All available vaccines in the European and North-American market are based on PCV2a genotype, while the most prevalent ones are PCV2b and PCV2d ones. Although significant level of cross-protection among these three genotypes has been demonstrated, it would be interesting to assess if vaccine efficiency would be equivalent in front of all these different genotypes.

Likecomment
share
My favorites
TwitterLinkedinTelegramTelegram
6 Like1 Comments
share
My favorites
24-Mar-2017chtouchweak 2 or 3 or..... for vaccination? not clear identification
TwitterLinkedinTelegramTelegram
Likecomment
share
My favorites
TwitterLinkedinTelegramTelegram
Like1 Comments
share
My favorites
05-Jan-2015Alex EggenThank you for this interesting paper. It is important to continue to stress that PCV2 related economic damage is a gradual scale. Pork producers often do not realise that by optimising their PCV2 protection protocol that they can have an even higher return on their investment. Secondly the CoV that you point out is equally important. Uniformity is a key element in our industry nowadays. The postive effect that PCV2 vaccination has on the level of uniformity and therewith the reduction in time needed to empty a barn, makes PCV2 vaccines a management tool!
TwitterLinkedinTelegramTelegram
Likecomment
share
My favorites
TwitterLinkedinTelegramTelegram
1 Like3 Comments
share
My favorites
22-Apr-2014jordi-guillaumet_1Hi Mr Gao,

in this article you will find more information about the genotypes distribution: https://www.pig333.com/circovirosis/novel-pcv2-variants-are-current-vaccines-protective_8488/
TwitterLinkedinTelegramTelegram
Like4 Comments
share
My favorites
16-Sep-2014msibilaKim et al., 2011. Comparative efficacy of commercial Mycoplasma hyopneumoniae and porcine circovirus 2 (PCV2) vaccines in pigs experimentally infected with M. hyopneumoniae and PCV2
Vaccine (29). 3206–3212.
TwitterLinkedinTelegramTelegram
Likecomment
share
My favorites

Welcome to 333

Connect, share, and interact with the largest community of professionals in the swine industry.

Celebrating 136908Users on 333!

Sign upAlready a member?
Recommended accounts
Wang  Lily

Wang Lily

Other - China
Zhou  Lydia

Zhou Lydia

Other - China
Idexx

Idexx

Company - Netherlands
Boehringer Ingelheim Vetmedica GmbH
Company - Germany
Crystal Spring Hog Equipment
Company - Canada